Drug reference

meningococcal b vaccine

protein-based vaccine · vaccine

protein-based vaccinevaccine

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

A four-component, protein-based vaccine incorporating fHbp, NadA, NHBA, and PorA P1.4 proteins to induce immunity against serogroup B meningococcal strains.

Indications

prevention of septicemia and meningitis caused by serogroup B meningococcal strains

Dosing

Adult: Teens and young adults (16–23 years old) also may get a serogroup B meningococcal vaccine.

Related guidelines

Infective endocarditis prevention

ADA_DENTAL · Dentistry · 2015

Stroke and TIA — secondary prevention

AHA · Neurology · 2021

Tobacco-related cancer prevention

ICMR · Oncology · 2021

Cardiovascular disease prevention

ESC · Cardiology · 2021

Primary prevention of cardiovascular disease

AHA · Cardiology · 2019

Ask House about meningococcal b vaccine

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team